Sputnik Light to be available in India by December; RDIF

Kirill Dmitriev, CEO of the Russian Direct Investment Fund (RDIF), stated on Wednesday that Russia’s single-dose Sputnik Light Covid-19 vaccine will be available in India by December 2021.

In July, India’s drug authorities denied the Russian-made vaccine emergency use authorization, stating out the requirement for a phase-3 trial. The Drugs Controller General of India (DCGI) granted Dr Reddy’s Laboratory Limited permission to undertake phase-3 bridging trials in September.

Sputnik Light is the same as component-1 of the Russian vaccine Sputnik V, which was approved for emergency use by India’s Drug Regulator in April and is now being used in the country’s anti-COVID inoculation programme.

According to data analysed from 28 days, after the injection was given as part of Russia’s mass vaccination campaign between December 5, 2020 and April 15, 2021, the single-dose Sputnik Light vaccine showed 79.4 percent efficiency.

According to a press statement from RDIF on May 6, Sputnik Light has proven efficient against all new coronavirus strains, as demonstrated by the Gamaleya Center during laboratory tests.